AMCA
VRTX icon

Arthur M. Cohen & Associates’s Vertex Pharmaceuticals VRTX Stock Holding History

Arthur M. Cohen & Associates’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Hold
490
– – 0.04% 127
2026
Q1 		$219K Sell
490
-300
-38% -$140K 0.04% 122
2025
Q4 		$358K Sell
790
-100
-11% -$43.1K 0.06% 99
2025
Q3 		$349K Hold
890
– – 0.06% 101
2025
Q2 		$396K Hold
890
– – 0.07% 95
2025
Q1 		$431K Hold
890
– – 0.08% 85
2024
Q4 		$358K Buy
890
+30
+3% +$13.9K 0.06% 106
2024
Q3 		$404K Hold
860
– – 0.07% 94
2024
Q2 		$403K Buy
860
+60
+8% +$26K 0.07% 97
2024
Q1 		$334K Hold
800
– – 0.07% 104
2023
Q4 		$326K Buy
800
+25
+3% +$9.23K 0.08% 103
2023
Q3 		$269K Hold
775
– – 0.07% 108
2023
Q2 		$273K Hold
775
– – 0.07% 109
2023
Q1 		$244K Buy
+775
New +$232K 0.07% 112
2022
Q4 		– Sell
-775
Closed -$224K – 133
2022
Q3 		$224K Hold
775
– – 0.06% 115
2022
Q2 		$202K Hold
775
– – 0.05% 126
2022
Q1 		$202K Buy
+775
New +$184K 0.04% 136
2020
Q4 		– Sell
-830
Closed -$226K – 150
2020
Q3 		$226K Hold
830
– – 0.06% 128
2020
Q2 		$241K Buy
+830
New +$225K 0.07% 110

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Arthur M. Cohen & Associates's VRTX Position: Q2 2026 in Review

Arthur M. Cohen & Associates held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 490 shares worth $243K. The position accounts for 0.04% of the portfolio, ranked #127.

Arthur M. Cohen & Associates first reported a position in VRTX in Q2 2020 and has held it in 19 quarters since. The position peaked at $431K in Q1 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Arthur M. Cohen & Associates held 490 shares of Vertex Pharmaceuticals worth $243K as of Q2 2026.
  • Arthur M. Cohen & Associates left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.04% of Arthur M. Cohen & Associates's portfolio in Q2 2026, its #127 holding.
  • Arthur M. Cohen & Associates first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 19 quarters since.
  • Arthur M. Cohen & Associates's Vertex Pharmaceuticals position peaked at $431K in Q1 2025.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Arthur M. Cohen & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.